Cheiron
Latest round
- Seed
Last raised
- Jul 2026
Total raised
- $8M
Investors
- 1
About Cheiron
Founded in 2024 by CEO Minseok Bae, CPO Jason Park and CTO Harshit Gupta, PhnyX Lab Inc.a. Cheiron operates out of California, US focusing on providing an integrated platform for drug program management in the biopharma industry. Cheiron offers a comprehensive AI-powered operating system designed specifically for the biopharma industry, enabling seamless integration of drug program management. Its core product connects various aspects of drug development, including protocols, submissions, study results, and regulatory commitments, into a unified platform. This system allows teams to promptly access relevant information when changes occur, ensuring that all stakeholders are informed and can respond effectively to updates. By streamlining workflows and providing a centralized repository for critical documents, Cheiron aims to enhance operational efficiency and reduce time to market for drug approvals. The company primarily serves pharmaceutical companies and research organizations across North America and Europe, providing tools that facilitate the management of complex drug development programs. Cheiron's revenue model revolves around subscriptions to its AI-driven operating system, catering to B2B transactions with pharmaceutical companies and biotech firms. The company generates income through tiered subscription plans that offer varying levels of access to its suite of tools and functionalities, tailored to the needs of different client sizes and project scopes. Engaging clients typically involves an initial setup fee, followed by recurring subscription payments that cover ongoing access to the platform and support services. Given its focus on drug program management, Cheiron’s offerings include proprietary features that assist clients with compliance, documentation, and regulatory processes. The structured nature of these transactions allows clients to budget effectively while ensuring they benefit from the latest advancements in drug program management technology.
Who invested in Cheiron
1 investor across 1 round
See all investors in Cheiron
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 22, 2026
Amount
$8M
Investors
Questions about Cheiron
Who invested in Cheiron?
Cheiron has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cheiron raised?
Cheiron has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cheiron last raise money?
Cheiron's most recent round on record is a Seed, in Jul 2026.
What does Cheiron do?
Founded in 2024 by CEO Minseok Bae, CPO Jason Park and CTO Harshit Gupta, PhnyX Lab Inc.
Where is Cheiron headquartered?
Cheiron is headquartered in Los Altos, US.
Which VCs invest in companies like Cheiron?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Cheiron's stage. Their profiles are linked below.
VCs backing software startups at Seed
Raising like Cheiron? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.